SCHEMBL624501

SCHEMBL624501

CCCCCCCCCCCCCCC[CH]C(=O)CCCCCCCCC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.56
PPARA Q07869 5/20 0.56
TERT O14746 3/20 0.55
PTPN1 P18031 3/20 0.55
PPARD Q03181 3/20 0.55
CYP1A2 P05177 2/20 0.55
MAPT P10636 2/20 0.55
CYP2C19 P33261 2/20 0.55
BLM P54132 2/20 0.55
HSD17B10 Q99714 2/20 0.55
FABP4 P15090 2/20 0.55
FAAH O00519 2/20 0.55
KMT2A Q03164 2/20 0.55
GMNN O75496 1/20 0.55
USP2 O75604 1/20 0.55
LMNA P02545 1/20 0.55
POLB P06746 1/20 0.55
CYP2C9 P11712 1/20 0.55
ALOX15 P16050 1/20 0.55
APEX1 P27695 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1405728 1.00 PPARG (0.56) PPARGPPARATERTPTPN1PPARD
SCHEMBL9868698 1.00 PPARG (0.56) PPARGPPARATERTPTPN1PPARD
SCHEMBL5583898 1.00 PPARG (0.56) PPARGPPARATERTPTPN1PPARD
SCHEMBL20189351 1.00 PPARG (0.56) PPARGPPARATERTPTPN1PPARD
SCHEMBL1173224 1.00 PPARG (0.56) PPARGPPARATERTPTPN1PPARD
SCHEMBL10645729 1.00 PPARG (0.56) PPARGPPARATERTPTPN1PPARD
SCHEMBL5179598 1.00 PPARG (0.56) PPARGPPARATERTPTPN1PPARD
SCHEMBL3397001 1.00 PPARG (0.56) PPARGPPARATERTPTPN1PPARD
SCHEMBL1685059 1.00 PPARG (0.56) PPARGPPARATERTPTPN1PPARD
SCHEMBL28417430 1.00 PPARG (0.56) PPARGPPARATERTPTPN1PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3294318-A1 PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF Aileron Therapeutics, Inc. (US) 2018-03-21 EP disclosed
WO-2016154058-A1 PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF AILERON THERAPEUTICS, INC. (US) 2016-09-29 WO disclosed
EP-2822572-A1 PEPTIDOMIMETIC MACROCYCLES Aileron Therapeutics, Inc. (US) 2015-01-14 EP disclosed
EP-2819688-A1 TRIAZOLE-CROSSLINKED AND THIOETHER-CROSSLINKED PEPTIDOMIMETIC MACROCYCLES Aileron Therapeutics, Inc. (US) 2015-01-07 EP disclosed
WO-2013123266-A1 PEPTIDOMIMETIC MACROCYCLES AILERON THERAPEUTICS, INC. (US) 2013-08-22 WO disclosed
WO-2013123267-A1 TRIAZOLE-CROSSLINKED AND THIOETHER-CROSSLINKED PEPTIDOMIMETIC MACROCYCLES AILERON THERAPEUTICS, INC. (US) 2013-08-22 WO disclosed
WO-2012021874-A1 PEPTIDOMIMETIC MACROCYCLES WITH THIOETHER LINKERS AILERON THERAPEUTICS, INC. (US) 2012-02-16 WO disclosed
WO-2012021875-A1 PEPTIDOMIMETIC MACROCYCLES WITH TRIAZOLE LINKERS AILERON THERAPEUTICS, INC. (US) 2012-02-16 WO disclosed